Dr. Jeffrey Fineman is a pediatric critical care specialist, or intensivist, and the division chief of Critical Care at UCSF Benioff Children’s Hospital, San Francisco. He also is an associate investigator of the Cardiovascular Research Institute. His research has led to new therapies for pulmonary hypertension, including a drug called inhaled nitric oxide, which was approved by the US Food and Drug Administration. Fineman's research has focused on diseases related to pulmonary circulation. In particular, he has been interested in the pathophysiology of pulmonary hypertension and heads a laboratory, funded by the National Institutes of Health, for these investigations.
This podcast is published in partnership with PhAware
Read the transcript for this podcast here.
Listen to “I’m Aware That I’m Rare: the phaware™ podcast” at www.phawarepodcast.libsyn.com. Learn more about pulmonary hypertension at www.phaware.global. #phaware
